Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.0100 (-2.62%) ($4.7901 - $5.1099) on Thu. Feb. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.28% (three month average) | RSI | 51 | Latest Price | $5.0100(-2.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.8% a day on average for past five trading days. | Weekly Trend | EYES advances 7.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) SHY(19%) TLT(13%) VCIT(12%) BND(10%) BNDX(10%) | Factors Impacting EYES price | EYES will decline at least -2.64% in a week (0% probabilities). URA(-13%) REMX(-12%) LIT(-12%) TBT(-11%) QQQ(-11%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.64% (StdDev 5.28%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $5.27(-4.93%) | 10 Day Moving Average | $5.02(-0.2%) | 20 Day Moving Average | $4.99(0.4%) | To recent high | -31.8% | To recent low | 0% | Market Cap | $1.6b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |